Advertisement
Resistance to the antibiotics clarithromycin

H. Pylori Resistance to Antibiotics Increasing

0
Bacteria frequently resistant to clarithromycin, metronidazole, levofloxacin
The Guidelines International Network has developed principles for disclosure and management of conflicts of interest during the clinical practice guideline development process

Guidelines Developed for Managing Conflicts of Interest

0
Core principles developed for managing COIs during the clinical practice guideline development process
In patients with heart failure with preserved ejection fraction

Nitrites Aid Heart Failure With Preserved Ejection Fraction

0
Sodium nitrite reduces hemodynamic derangements of cardiac failure that occur with exercise
Inclusion of the coronary artery calcium score improves coronary heart disease risk prediction

Coronary Artery Calcium Score Improves CHD Risk Prediction

0
And, absence of CAC reclassifies about half of patients as being not eligible for statins
Surveillance of seven U.S. metropolitan areas found higher-than-expected levels of carbapenem-resistant Enterobacteriaceae in Atlanta

CDC Warns of Carbapenem-Resistant Enterobacteriaceae

0
Evidence of CRE found in seven U.S. cities monitored by researchers
For intensive care unit (ICU) patients with fever due to probable infection

Acetaminophen Given Early Doesn’t Cut ICU Days

0
No impact on number of ICU-free days in patients with fever due to probable infection
California Gov. Jerry Brown signed "right-to-die" legislation on Monday that will allow the terminally ill to legally end their lives.

California Governor Signs Right-to-Die Bill Into Law

0
Physicians can now prescribe life-ending drugs to terminally ill
Aristada (aripiprazole lauroxil) extended-release injection has been approved by the U.S. Food and Drug Administration to treat schizophrenia

FDA OKs Long-Acting Atypical Antipsychotic for Schizophrenia

0
Aristada (aripiprazole lauroxil) is injected every four-to-six weeks
The incidence of cytomegalovirus infection/disease is reduced in de novo kidney transplant recipients receiving reduced dose tacrolimus and everolimus

Reduced-Dose Tacrolimus, Everolimus Cuts CMV Infection

0
Findings in de novo kidney recipients receiving no pharmacologic CMV prophylaxis
Adoption of a recommended bundle of prevention behaviors is associated with a reduction in the pediatric surgical site infection rate

Prevention Bundle Can Cut Rate of Pediatric SSIs

0
Twenty-one percent reduction in SSI rate reported across network hospitals